-
UK public urged to keep eyes peeled for washed-up bananas
-
South Korea chip giant SK hynix mulls US stock market listing
-
Captain Cummins back in Australia squad for third Ashes Test
-
NFL Colts to bring 44-year-old QB Rivers out of retirement: reports
-
West Indies 92-2 after being asked to bat in second New Zealand Test
-
Ruckus in Brazil Congress over bid to reduce Bolsonaro jail term
-
ExxonMobil slows low-carbon investment push through 2030
-
Liverpool's Slot swerves further Salah talk after late Inter win
-
Maresca concerned as Atalanta fight back to beat Chelsea
-
Liverpool edge Inter in Champions League as Chelsea lose in Italy
-
Spurs sink Slavia Prague to boost last-16 bid in front of Son
-
Arsenal ensure Women's Champions League play-off berth
-
Canada launches billion dollar plan to recruit top researchers
-
Liverpool defy Salah crisis by beating Inter Milan in Champions League
-
Honduran leader alleges vote tampering, US interference
-
De Ketelaere inspires Atalanta fightback to beat Chelsea
-
Kounde double helps Barcelona claim Frankfurt comeback win
-
US Supreme Court weighs campaign finance case
-
Zelensky says ready to hold Ukraine elections, with US help
-
Autistic Scottish artist Nnena Kalu smashes Turner Prize 'glass ceiling'
-
Trump slams 'decaying' and 'weak' Europe
-
Injury-hit Arsenal in 'dangerous circle' but Arteta defends training methods
-
Karl and Gnabry spark Bayern to comeback win over Sporting
-
Thousands flee DR Congo fighting as M23 closes on key city
-
Indigenous artifacts returned by Vatican unveiled in Canada
-
Ivory Coast recall Zaha for AFCON title defence
-
Communist vs Catholic - Chile prepares to choose a new president
-
Trump's FIFA peace prize breached neutrality, claims rights group
-
NHL 'optimistic' about Olympic rink but could pull out
-
Thousands reported to have fled DR Congo fighting as M23 closes on key city
-
Three face German court on Russia spying charges
-
Amy Winehouse's father sues star's friends for auctioning her clothes
-
Woltemade's 'British humour' helped him fit in at Newcastle - Howe
-
UK trial opens in dispute over Jimi Hendrix recordings
-
Pandya blitz helps India thrash South Africa in T20 opener
-
Zelensky says will send US revised plan to end Ukraine war
-
Miami's Messi wins second consecutive MLS MVP award
-
Trump slams 'decaying' Europe and pushes Ukraine on elections
-
TotalEnergies in deal for Namibia offshore oil field
-
Jesus added to Arsenal's Champions League squad
-
Red Bull part ways with influential advisor Marko
-
India's biggest airline IndiGo says operations 'back to normal'
-
Venezuela's 'joropo' dance declared a UNESCO treasure
-
Salah trains in Liverpool as Saudis plan winter transfer move
-
Police raid Argentine football HQ, clubs in graft probe
-
Ukraine should hold elections, Trump says
-
Anguished Sri Lankans queue for care after deadly cyclone
-
Save the Elephants founder Iain Douglas-Hamilton dies at 83
-
Why west African troops overturned Benin's coup but watched others pass by
-
Microsoft announces $17.5 bn investment in India, its 'largest ever' in Asia
Nobel chemistry winner sees engineered proteins solving tough problems
Whether it's battling tumors or breaking down plastic, American scientist David Baker, co-recipient of this year's Nobel Prize in Chemistry, has an answer: engineering proteins that don't naturally exist -- a concept once dismissed as "crazy."
Today, proteins with novel functions are flowing steadily out of his lab, with an endless list of potential applications ranging from ultra-targeted therapies to the development of new vaccines.
"Across the range of problems that we face today in medicine and health, sustainability, energy, and technology, I think the potential for protein design is enormous," Baker told AFP via video call from Seattle, hours after learning of his Nobel win alongside two other laureates.
Proteins are organic molecules that play a fundamental role in almost every function of living organisms, from muscle contraction and food digestion to neuron activation and more.
"The ones in nature evolved to solve all the problems that were faced during natural selection," explained the 62-year-old University of Washington professor.
"But humans face new problems today," added the biochemist and computational biologist.
"We're heating up the planet, so we need new solutions in ecology and sustainability. We live longer, so there's new diseases which are relevant, like Alzheimer's disease. There's new pathogens like coronavirus."
Rather than leave these problems up to evolution -- a "brutal" solution that would take a very, very long time -- "with new proteins, we can solve those problems, but in a very short time," he said.
- From fringe to mainstream -
All proteins are composed of chains of amino acids, whose sequence dictates their shape -- and ultimately their function.
For decades, scientists have tried to determine protein structures based on these amino acid sequences.
In the late 1990s, Baker made strides towards solving this problem with a computer software he developed called Rosetta.
His success prompted a shift his focus to the reverse approach: starting with a desired shape and using Rosetta to identify the corresponding amino acid sequence. This sequence can then be introduced into bacteria, which synthesize the new protein that can be harvested and studied.
In 2003, he published his breakthrough finding -- the creation of the first-ever protein not found in nature -- though it still lacked a defined function.
"Then we started trying to design proteins that actually would do useful things," Baker recalled. "And that's when people, I think, really started thinking it was crazy."
But "for the last 20 years -— and really, most recently, the last five years -— we've been able to make proteins that do all kinds of amazing things," he said. Rosetta meanwhile has been progressively improved to incorporate artificial intelligence.
"I think what's kind of funny now is that the lunatic fringe, which pretty much no one was doing, has now entered the mainstream," he added with a laugh.
- Keys that fit locks -
How do scientists decide what shape a new protein needs to achieve the desired function?
Baker gives the example of a tumor. "We know some protein that's on the surface of that tumor, and we know its shape. What we do is we design a protein that acts like a key fitting into a lock," he explained.
Another application: breaking down plastic. In this case, a protein is designed to attach itself to the plastic molecule, accompanied by chemical compounds to "cut" it.
In medicine, this technology has already been used in a Covid-19 vaccine approved in South Korea. Researchers are also exploring its potential to create new materials.
"In biology, we have tooth and bone, we have shells, which are made by proteins interacting with inorganic compounds like calcium carbonate or calcium phosphate," says Baker, envisioning proteins interacting with other compounds to create entirely new materials with unique properties.
Greenhouse gas capture, a universal flu vaccine, improved antivenom -- Baker's wish list goes on and on.
"As protein design becomes more powerful, I'm incredibly excited about all the problems that we will be able to solve."
V.Dantas--PC